Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896740 · ClinicalTrials.gov registry record
Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Terminated
- Registry status
- 90
- Enrollment target
NCT00896740 is a clinical trial that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 90 participants.
The verdict
NCT00896740 was terminated before completion, sponsored by OHSU Knight Cancer Institute.
- TERMINATED
- Registry status
- 90 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of bone marrow from patients with Fanconi anemia and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to Fanconi anemia. PURPOSE: This laboratory study is evaluating gene function in bone marrow cells from patients with Fanconi anemia and from healthy participants.
Interventions
- GENETIC microarray analysis
- PROCEDURE biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2002-03 |
| Est. Completion | 2007-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00896740
The ClinicalTrials.gov registry entry for NCT00896740 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which microarray analysis is the first listed.
NCT00896740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00896740 about?
NCT00896740 is a clinical study titled "Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants". RATIONALE: Studying samples of bone marrow from patients with Fanconi anemia and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to Fanconi anemia. PURPOSE: This laboratory study is evaluating gene function in b...
What is the current status of trial NCT00896740?
This trial is currently terminated. The enrollment target is 90 participants. The study started on 2002-03. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00896740?
The interventions under investigation include: microarray analysis (GENETIC), biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00896740?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.